Weidmann E - Search Results

1

Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.

Karbach J, Gnjatic S, Bender A, Neumann A, Weidmann E, Yuan J, Ferrara CA, Hoffmann E, Old LJ, Altorki NK, Jäger E. Karbach J, et al. Among authors: weidmann e. Int J Cancer. 2010 Feb 15;126(4):909-18. doi: 10.1002/ijc.24850. Int J Cancer. 2010. PMID: 19728336

2

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates.

Karbach J, Gnjatic S, Biskamp M, Atmaca A, Weidmann E, Brandt K, Wahle C, Bernhard H, Knuth A, Jäger E. Karbach J, et al. Among authors: weidmann e. Cancer Immunol Res. 2014 May;2(5):404-9. doi: 10.1158/2326-6066.CIR-13-0200. Epub 2014 Feb 5. Cancer Immunol Res. 2014. PMID: 24795353

3

Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.

Al-Batran SE, Rafiyan MR, Atmaca A, Neumann A, Karbach J, Bender A, Weidmann E, Altmannsberger HM, Knuth A, Jäger E. Al-Batran SE, et al. Among authors: weidmann e. Cancer Res. 2005 May 1;65(9):3937-41. doi: 10.1158/0008-5472.CAN-04-4621. Cancer Res. 2005. PMID: 15867394

4

LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.

Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. Bender A, et al. Among authors: weidmann e. Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.

5

Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.

Al-Batran SE, Kerber A, Atmaca A, Dechow C, Reitsamer E, Schmidt S, Kolassa Y, Neumann A, Weidmann E, Hartmann JT, Jäger E. Al-Batran SE, et al. Among authors: weidmann e. Onkologie. 2007 Feb;30(1-2):29-34. doi: 10.1159/000097768. Epub 2007 Jan 26. Onkologie. 2007. PMID: 17264523 Clinical Trial.

6

Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer.

Friedmann I, Atmaca A, Chow KU, Jäger E, Weidmann E. Friedmann I, et al. Among authors: weidmann e. J Chemother. 2006 Aug;18(4):415-20. doi: 10.1179/joc.2006.18.4.415. J Chemother. 2006. PMID: 17024798

7

Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas.

Weidmann E, Neumann A, Fauth F, Atmaca A, Al-Batran SE, Pauligk C, Jäger E. Weidmann E, et al. Ann Oncol. 2011 Aug;22(8):1839-44. doi: 10.1093/annonc/mdq671. Epub 2011 Jan 21. Ann Oncol. 2011. PMID: 21257672 Free article. Clinical Trial.

8

A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.

Weidmann E, Hess G, Chow KU, Krause SW, Subklewe M, Kruse J, Weisel KC, Soekler M, Kim SZ, Napieralski S, Rech J, Dreyling M, Jäger E, Mitrou PS. Weidmann E, et al. Leuk Lymphoma. 2010 Mar;51(3):447-55. doi: 10.3109/10428190903580402. Leuk Lymphoma. 2010. PMID: 20141439 Clinical Trial.

9

Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.

Bergmann L, Fenchel K, Weidmann E, Enzinger HM, Jahn B, Jonas D, Mitrou PS. Bergmann L, et al. Among authors: weidmann e. Cancer. 1993 Sep 1;72(5):1733-42. doi: 10.1002/1097-0142(19930901)72:5<1733::aid-cncr2820720537>3.0.co;2-x. Cancer. 1993. PMID: 8348502 Clinical Trial.

10

Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.

Karakas T, Bergmann L, Stutte HJ, Jäger E, Knuth A, Weidmann E, Mitrou PS, Hoelzer D. Karakas T, et al. Among authors: weidmann e. Leuk Lymphoma. 1996 Dec;24(1-2):121-9. doi: 10.3109/10428199609045720. Leuk Lymphoma. 1996. PMID: 9049968 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters